DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Kaufman JL, Niesvizky R, Stadtmauer EA. , et al.
Phase I, multicentre, dose-escalation trial of monotherapy with milatuzumab (humanized anti-CD74 monoclonal antibody) in relapsed or refractory multiple myeloma.
Br J Haematol 2013;
163 (04) 478-486
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.